BiotechTube
Siron Clinical

Siron Clinical

Amsterdam, Netherlands· Est.
sironclinical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Siron Clinical is a private, revenue-generating CRO offering a full-service and FSP model for clinical trial management, primarily in Europe. It leverages deep regional expertise to help sponsors, particularly in biotech, overcome the complexities of the EU Clinical Trials Regulation and local country-specific requirements. The company's value proposition centers on experienced teams, flexible partnership models, and a focus on therapeutic areas with high unmet need, such as orphan and pediatric diseases. Its business model is purely service-based, providing operational support rather than developing its own therapeutic assets.

Orphan/Rare DiseasesPediatricsMedical Devices

Technology Platform

Operational methodology and regional expertise in European clinical trials; implements (but does not own) modern trial technologies like AI for recruitment and patient-centric/digital trial models.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

Growing demand from biotech sponsors for nimble, expert European operational partners.
The EU CTR and complex therapeutic areas (orphan, pediatric) create a need for specialized local knowledge that large CROs may not provide as effectively.
Increasing adoption of decentralized and digital trial components opens avenues for service innovation.

Risk Factors

High competition from large, global CROs with greater resources.
Revenue dependency on the funding health of the small-to-midsize biotech sector, which is cyclical.
Operational risk associated with retaining top talent and maintaining flawless regulatory compliance across multiple European countries.

Competitive Landscape

Competes in a fragmented CRO market. Faces direct competition from large global full-service CROs (e.g., IQVIA, ICON) and other regional European boutique CROs. Differentiation is based on deep regional expertise, personalized service, and focus on complex trials, rather than scale or low cost.

More companies in Digital Health & Biotech SaaS →More companies in Netherlands →